The Food and Drug Administration (FDA) issued final guidance Monday that explains how medical device manufacturers can use a Predetermined Change Control Plan (PCCP) to update AI-enabled device software functions (AI-DSFs) after clearance or approval without submitting a new marketing application for each covered change.
The guidance is a practical how‑to for getting the FDA
